SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (632)8/28/2001 8:38:05 AM
From: Extra Pale  Respond to of 2243
 
"Seems like there was a third??"

ISIP with its crohns drug had a Maxim type blowup a couple of years ago - an event that I suspect is still on investors minds.



To: scaram(o)uche who wrote (632)8/28/2001 11:18:46 AM
From: Biomaven  Read Replies (1) | Respond to of 2243
 
Seems like there was a third??

I would add PCYC to this list. Also the subject of some controversy and a short attack, and the price has continued weak.

Peter



To: scaram(o)uche who wrote (632)8/28/2001 1:43:18 PM
From: keokalani'nui  Read Replies (1) | Respond to of 2243
 
A Third? I suggest ALXN, with its "it depends" phase 2 results.

(If Peter can suggest one, pcyc, I once owned and sold, I can suggest one, alxn, he once owned and sold. Unfortunately for me he's a better investor; and more gracious, erudite and...well, enough comparisons.)

Wilder


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News